GLOBAL GREEN INC COM NPV (GOGC)

0.02
OTC Markets
Prev Close 0.02
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.00 / 0.00
Exchange OTC Markets
Shares Outstanding 745.76B
Market Cap 14.92M
Div & Yield N.A. (N.A)

Global Green Responds To SEC Action

Global Green, Inc. (Pink Sheets:GOGC), a green bio-pharmaceutical company, announces that the SEC halted trading in its common stock.

Global Green, Inc. Announces Extension Of Agreement With Merial For Evaluation Of Salmonella Vaccine And License Option

Global Green, Inc. (OTCBB:GOGC), a green bio-pharmaceutical company, announces today the 90-day extension of an existing agreement with Merial Ltd.

Global Green, Inc. To Proceed With Plans To Construct A Manufacturing Facility

Global Green, Inc. (OTCBB:GOGC), a green bio-pharmaceutical company, today announced that it has made a tactical decision to proceed with the design and development of plans to construct a manufacturing facility ...

Global Green, Inc.’s Salmonella Vaccine Could Meet The Eight Point Ideal Vaccine Criteria Outlined At Poultry Science Outlook Seminar

Global Green, Inc. (OTCBB:GOGC), a green bio-pharmaceutical company, today announced that its patented Salmonella vaccine for poultry, Salmogenics, could meet all ideal vaccine criteria as outlined by Professor Paul...

Global Green, Inc. Poultry Vaccine For Salmonella To Offer Chemical-Free Solution

Global Green, Inc. (OTCBB:GOGC) cites an article in last month’s Washington Post that the U.

Global Green, Inc. Signs Agreement With Merial For Evaluation Of Salmonella Vaccine And License Option

Global Green, Inc. (OTCBB:GOGC) announces today the signing of an agreement with Merial Ltd.

Global Green’s Salmonella Vaccine Produces No Stress In Poultry And Strengthens Immune System

Global Green, Inc. (OTCBB:GOGC) today announced that Salmogenics, the Company’s patented Salmonella vaccine for poultry, produces no stress in poultry.

Global Green’s Salmonella Vaccine May Reduce The Use Of Antibiotics In Poultry

Global Green, Inc. (OTCBB:GOGC) today announced that Salmogenics, the Company’s patented Salmonella vaccine for poultry, may reduce the use of antibiotics in poultry.

Global Green, Inc. Announces Trial Studies Indicate Use Of Salmogenics May Improve Performance Of Broilers

Salmogenics-Vaccinated Broilers Experienced Weight Gain, Feed Conversion Improvement, and Reduced Mortality Over Control Birds

Global Green, Inc. Announces DTC Eligibility

Company's Patented Salmonella Vaccine in Final Stage of USDA Approval

Global Green, Inc. Announces Appointment Of Konky Sotomayor, DVM As Chief Scientist

Global Green, Inc. (OTCBB:GOGC) today announced the appointment of Konky Sotomayor, DVM as Chief Scientist of the Company.

Global Green, Inc. Cites Recent Industry Studies That Reinforce Significance Of Its Salmonella Vaccine, Salmogenics

Global Green, Inc. (OTCBB:GOGC) cites recent leading industry studies that emphasize how difficult Salmonella bacteria is to avoid and to eradicate.